gga:
I wanted Biotech's view on this question about the technology...but he's not around or maybe not interested.
With an ex Oracle senior executive, and top scientists on the case, I don't think PSY is unprofessional, it is underfunded. They are entering the most expensive phase, the commercialisation phase and they are very squeezed financially. This affects their negotiating position.
This is where they either get a partner, sell licences to a high profile party or sell the technology to the highest bidder. Annoyingly their SP is nearly double ours.
- Forums
- ASX - By Stock
- ADO
- brr interview Tue, 2 Sep 2014 10:30am - Anteo enters into additional agreement
brr interview Tue, 2 Sep 2014 10:30am - Anteo enters into additional agreement, page-57
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.414K | 161.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 616353 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 0.021 |
12 | 2157550 | 0.020 |
10 | 3040767 | 0.019 |
10 | 1652665 | 0.018 |
4 | 194160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 616353 | 6 |
0.023 | 857853 | 5 |
0.024 | 1306228 | 3 |
0.025 | 254144 | 5 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |